Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
| Title: | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. |
|---|---|
| Authors: | Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F; Drappatz J; O'Rourke DM; Wong M; Hamilton MG; Finocchiaro G; Perry J; Wick W; Green J; He Y; Turner CD; Yellin MJ; Keler T; Davis TA; Stupp R; Sampson JH; Soffietti R; ACT IV trial investigators |
| Contributors: | Weller, M; Butowski, N; Tran, Dd; Recht, Ld; Lim, M; Hirte, H; Ashby, L; Mechtler, L; Goldlust, Sa; Iwamoto, F; Drappatz, J; O'Rourke, Dm; Wong, M; Hamilton, Mg; Finocchiaro, G; Perry, J; Wick, W; Green, J; He, Y; Turner, Cd; Yellin, Mj; Keler, T; Davis, Ta; Stupp, R; Sampson, Jh; Soffietti, R; ACT IV trial investigators |
| Publication Year: | 2017 |
| Collection: | Università degli studi di Torino: AperTo (Archivio Istituzionale ad Accesso Aperto) |
| Document Type: | article in journal/newspaper |
| Language: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/wos/WOS:000411843500053; firstpage:1373; lastpage:1385; numberofpages:13; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/2318/1656201; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85028303336 |
| Availability: | http://hdl.handle.net/2318/1656201 |
| Rights: | info:eu-repo/semantics/closedAccess |
| Accession Number: | edsbas.C7F7ABDB |
| Database: | BASE |